宫颈癌图像引导近距离放疗中基于CT与基于MRI的高危临床靶体积比较:参照日本放射肿瘤学研究组(JROSG)建议与欧洲近距离放疗协作组-欧洲放射肿瘤学会(GEC ESTRO)共识指南
本研究纳入14例宫颈癌患者,在置入CT/MR施源器后行CT和MRI,分别参照JROSG建议在CT上勾画HR-CTV(HR-CTVCT)和参照GEC ESTRO共识指南在MRI上勾画HR-CTV(HR-CTVMR),比较两者体积及基于曼彻斯特系统6 Gy剂量的剂量学。HR-CTVMR中位体积24.4 ml,HR-CTVCT中位体积29.9 ml;中位D90分别为6.7 Gy和6.8 Gy。结论认为两者之间存在一定差异。
要点
- HR-CTVCT中位体积29.9 ml,大于HR-CTVMR的24.4 ml。
- HR-CTVMR中位D90为6.7 Gy,HR-CTVCT中位D90为6.8 Gy。
- 基于CT参照JROSG建议勾画的HR-CTV与基于MRI参照GEC ESTRO指南勾画的HR-CTV存在一定差异。
核心结论
- 基于CT参照JROSG建议勾画的HR-CTV与基于MRI参照GEC ESTRO共识指南勾画的HR-CTV之间存在一定差异。
研究设计与样本
- 本研究为自身对照研究,共评估14例宫颈癌患者。
- 置入CT/MR施源器后行CT和MRI检查。
- HR-CTVMR在MRI上勾画用于临床检查;HR-CTVCT在CT上回顾性勾画,参照近距离放疗前一周内的MRI。
- 评估基于曼彻斯特系统6 Gy剂量的HR-CTV体积和剂量学。
诊断标准与关键数值
- HR-CTVMR中位体积为24.4 ml(范围13.6–50.4 ml),HR-CTVCT中位体积为29.9 ml(范围13.2–49.2 ml)。
- HR-CTVMR中位D90为6.7 Gy(范围5.8–10.1 Gy),HR-CTVCT中位D90为6.8 Gy(范围5.1–10.4 Gy)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The Working Group of the Gynecological Tumor Committee of the Japanese Radiation Oncology Study Group (JROSG) published recommendations for contouring high-risk clinical target volumes (HR-CTV) on CT for 3-dimentional image-guided brachytherapy for cervical cancer. The purpose of this study was to compare HR-CTV delineated on CT, referencing recommendations from JROSG, with HR-CTV delineated on MRI, referencing consensus guidelines from the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC ESTRO).
MATERIAL AND METHODS: Fourteen patients were evaluated. After the insertion of the CT/MR applicator into the patient, CT and MRI were performed. HR-CTVMR was delineated on MRI for clinical examination and HR-CTVCT was delineated on CT retrospectively referencing the MRI just before brachytherapy within a week. The volume and dosimetry of HR-CTV based on a 6 Gy dose of the Manchester system were evaluated.
RESULTS: The median volumes of HR-CTVMR and HR-CTVCT were 24.4 ml (range, 13.6-50.4 ml) and 29.9 ml (range, 13.2-49.2 ml), respectively. Median D90 of HR-CTVMR and HR-CTVCT were 6.7 Gy (range, 5.8-10.1 Gy) and 6.8 Gy (range, 5.1-10.4 Gy), respectively.
CONCLUSION: Somewhat difference could be seen between HR-CTVMR and HR-CTVCT.
引用
- Iwai Y, Nemoto MW, Horikoshi T, et al. Comparison of CT-based and MRI-based high-risk clinical target volumes in image guided-brachytherapy for cervical cancer, referencing recommendations from the Japanese Radiation Oncology Study Group (JROSG) and consensus statement guidelines from the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC ESTRO). Jpn J Radiol. 2020. PMID: 32333219. doi:10.1007/s11604-020-00980-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。